Evolving molecular subtyping of breast cancer advances precision treatment.

IF 5.6 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Cancer Biology & Medicine Pub Date : 2024-09-19 DOI:10.20892/j.issn.2095-3941.2024.0222

Rui Shan, Lei-Jie Dai, Zhi-Ming Shao, Yi-Zhou Jiang

引用次数: 0

查看原文本刊更多论文

不断发展的乳腺癌分子亚型推进了精准治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Biology & Medicine Medicine-Oncology

CiteScore

9.80

自引率

3.60%

发文量

1143

审稿时长

12 weeks

期刊介绍： Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.